Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 96Ovarian Neoplasms 54Endometrial Neoplasms 36Carcinoma, Ovarian Epithelial 22Fallopian Tube Neoplasms 19Neoplasms 11Uterine Cervical Dysplasia 9Papillomavirus Infections 7Recurrence 6Ovarian Cysts 6Vulvar Neoplasms 5Lymphatic Metastasis 5Uterine Neoplasms 4Peritoneal Neoplasms 4Gynecologic Cancer 4Colonic Neoplasms 4Pancreatic Neoplasms 3Malnutrition 3Hereditary Breast and Ovarian Cancer Syndrome 3Esophageal Neoplasms 3Endometrial Hyperplasia 3Carcinoma 3Breast Neoplasms 3Anxiety Disorders 3Stomach Neoplasms 2Radiation Injuries 2Polycystic Ovary Syndrome 2Peripheral Nervous System Diseases 2Patient Compliance 2Pain 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Cervical Cancer Recurrent × Gynecologic × Clear all
NCT06455046 2024-06-12

Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer

Fujian Cancer Hospital

Phase 2 Recruiting
37 enrolled
Gynecologic

Cervical Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon âš¡